key: cord-0909150-404tjm3v authors: Shiva, Saravana; Mari, Shanmugam; Amuthan, Arul; Shanmugam, Ramalingam title: Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile date: 2021-06-30 journal: J Ayurveda Integr Med DOI: 10.1016/j.jaim.2021.06.009 sha: b45e9469ee9c8aa10d321eefa2c0605925105912 doc_id: 909150 cord_uid: 404tjm3v BACKGROUND: Vajra kandi maathirai (VKM) is a mercury based traditional Siddha drug used to treat various types of fevers and inflammatory diseases. We report our experience of using VKM successfully to treat 5 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and its chemical profile. CASE REPORT: A family with 5 members age ranges between 13 to 77, both male and females, one with preexisting renal impairment, SARS CoV-2 positive with mild to moderate category were treated with VKM along with the specific dietary practice. The drug was consumed at home quarantine. Real-Time RT PCR from oropharynx swab, X-ray/CT scan chest, hematology, renal function, liver function, body temperature and oxygen saturation were assessed. Blood parameters were repeated after completion of therapy to assess the safety aspect of mercury drug. Chemical profile of the drug was done using Gas chromatography-mass spectrometry and inductively coupled plasma mass spectrometry. RESULTS: With the first dose, the oxygen saturation was improved. Within 3 days of therapy, all symptoms (fever, body pain, cough, and loss of taste) were normalized and renders the Real-Time RT PCR negative for COVID-19. There was no observed side effects and damage to renal and liver. The drug contains 22% of mercury along with a 9-Octadecenoic acid-(E), 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl) and 9,12-Octadecadienoic acid (Z,Z)- as major organic compounds. CONCLUSION: Vajra kandi maathirai might be a safe drug to manage COVID-19 patients. Rigorous research is required to discover new antiviral molecules from this formulation. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the ongoing outbreak of coronavirus disease 2019 (COVID-19) pneumonia globally. The transmission rate is very high and many are in the asymptomatic or mild stage. Moderate phase patients present cough and shortness of breath, whereas the severe phase patients have the septic shock with multiorgan failures [1] . India and China have added traditional medical systems along with conventional treatment protocol as an integrative approach to prevent and treat SARS-CoV2 infection [2, 3] . The traditional Siddha medical system, established by Tamil yogis (Siddhar) classifies the diseases into 4448 types and also describes their specific treatment modalities [4] . Siddhar Agastyar (father of this medical system) and Siddhar Yugi have authored two literatures exclusively for fever, named as sura nool (Textbook on Fever) and kaaviya sura nool (Treatise herbal steam inhalation, herbal powder snuffing herbal decoction (aqueous extracts), syrups, tablets, dietary practices, metal/mineral based drugs, and animal origin drugs are used in Siddha to treat fevers [5, 6] . Siddhar Patanjali (lived between 500 BC to 800 A.C) [7] is the Father of Yoga, who had also authored many Siddha books; and he described a mercury-based Vajra kandi maathirai (antifever pill) for the treatment of all kind of fevers. The Vajra (vajram) mean hardness/strongness like diamond or hardcore, kandi means a rebuke or condemn or denounce without fail and maathirai means tablet or pill. So, the Vajra kandi maathirai means a pill that can denounce strongly without fail against life-threatening conditions. The preparation method, indications and dietary practices during the therapy have been described in detail in a Siddha literature "Siro Rathina Nadana kaandam" [8] , written during the 17 th -18 th century by an unknown Siddha practitioner, but this palm manuscript was preserved in Tamil Nadu Archeology Department [8] . This pill is indicated for all types of acute or severe or chronic fevers (64 types of suram) with or without multi-organ failure (janni) [9, 10] . J o u r n a l P r e -p r o o f infectious discharge in the urethra (vellai), severe inflammation and pain in major joints (mega kudaichchal), small joint inflammation due to autoimmune causes (kanu vaatham), infectious orchitis (virai vaatham), infected ulcers (pun purai) and meningitis (moorchai vaayu). [11] During 1950, the retired Judge Dr.Balaramaiah from Chennai, India has documented the successful practices of this drug by many local Siddha vaidyars for the abovementioned conditions [12] . Even now, the same drug is being prescribed by many Siddha physicians for life-threatening infectious (viral, bacterial) conditions, inflammatory conditions and autoimmune diseases. Based on our prior experiences, Siddha practitioners have proposed to use this drug for treating SARS-CoV-2 [9] . So far, no scientific literature is available on its clinical efficacy in COVID-19 cases, safety and chemistry. In this manuscript, we report the efficacy of VKM in 5 cases with SARS-CoV-2 infection, its safety and chemical profile. A family with 5 members comprising of the grandmother (77 years-patient 1), the father (45 years-patient 2), the mother ( Patient-1 has preexisting chronic renal failure: With the age of 77, her renal function markers in serum (urea, creatinine, and uric acid) levels were elevated. On 19 May 2020, patient-3, 4 and 5 were also developed fever (ranges between 100-103 o F), tiredness, and headache. All of 5 members consumed paracetamol tablets as self-medication. Since fever continued, all the five patients visited the hospital on 21 May 2020 with acute febrile illness. Patient-3, 4 and 5 also underwent RT-PCR test from nasopharyngeal/ oropharyngeal swab for SARS CoV-2 that showed positive result. X-ray chest, blood cell counts and liver-renal function test were also performed. Since the patient-1 was having cough, plain CT chest was J o u r n a l P r e -p r o o f performed, which showed the multiple patches of ground-glass opacities in all the lobes of both the lungs and crazy paving pattern in right lower lobe with CT severity score of 11. There was no pleural fluid and all other structures were normal. X-ray chest of Patient-4 showed the subtle patchy opacities in the left lower zone, but clinically there was no cough or other lung symptoms (Table 1, Figure 1 ), whereas the X-ray was normal for rest of the family members. All of them were advised for home quarantine with daily monitoring of body temperature and oxygen saturation. They were prescribed drugs for symptomatic management. Elder daughter additionally received probiotics since she was having diarrhea. Table 1) . The cough and fever were increasing to patient-1 for > 10 After reaching home at night on 25 May 2020, the family contacted our clinic and was given the Figure 2 ,3). For patient-2, VKM was given thrice daily for three days (26 -28 May) followed by twice daily on 29 May. Her temperature and all other symptoms were normalized with 11 doses for 4 days. Rest of the three patients consumed 9 doses of VC for a total of three days from 26 -28 May (thrice daily) (Table 1) . While taking VKM, the conventional therapy has been stopped. The capsule is to be consumed with hot water or diluted honey with hot water. The patients were strictly advised to consume a recipe from/using any of the following; rice porridge, rice + milk porridge, wheat porridge, Idly, Idiyappam (string hoppers), green gram, tender drumstick, pepper, beans, dry mutton Meat/Jerked mutton meat, and Rain quail. Tamarind, sour tasty fruits/vegetables, alcohol, tobacco, bitter gourd, chicken, beef meat, fish should be avoided during these days. The diet restriction is usually advised to be continued for at least two more J o u r n a l P r e -p r o o f weeks from the last dose of VKM, this is called as maru pathiyam. The idea here is to avoid drug-food interactions, to get maximum efficacy, to favor mercury elimination from the body, and to restore or reverse the toxicity, if any; so that the desired efficacy could be achieved safely. Adverse effect monitoring: The patient was followed by telephonically weekly to observe any side effects. After the maru pathiyam (two weeks after the last dose of VKM with continuing dietary practices), the renal function, liver function and blood cells were evaluated. There were no side effects reported by all the patients and no abnormalities in blood parameters. Patient-2 had chronic kidney disease, with the pretexting elevated renal markers in the blood that remains the same even after the vajrakandi maathirai (Table 1, Figure 2 ,3). The SpO2 was elevated from 82% to 90% within one day after VKM therapy and subsequently it was maintained in a good status. All have improved in fever and other clinical symptoms satisfactorily. On 2 Jun 2020, the RT-PCR was repeated to all five members and found to be negative. All the cases were able to follow our instructions including dietary practices. They are healthy after this incident, even for many months without any post covid complications. No adverse J o u r n a l P r e -p r o o f effects were observed. Patients were very happy for the cost effective treatment for COVID-19, without hospitalization. The cost of a single dose of VKM ranges from INR 15 to 50. In our case, the total expenditure for treating patient-1 (16 doses), patient-2 (11 doses), and others (9 doses The vajrakandi maathirai was subjected for the chemical profiling using standard procedures of gas chromatography-mass spectrometry (ethyl acetate extract of VKM) for organic and inductively coupled plasma mass spectrometry for inorganics respectively [13, 14] . It contains 22% mercury, 8.7% iron, and 1.3% arsenic along with 66 phytochemicals, among VKM controlled the fever and other symptoms to all the 5 patients, and also improved the oxygen saturation significantly immediately with the first dose in patient-1. The duration of COVID symptoms during conventional therapy is 8 -19 days [15, 16] . In our cases, the duration of the symptoms is 8 -12, in which first one week they were under conventional therapy that did not showed any improvement in symptoms, but the symptoms are relieved significantly with the VKM treatment. The duration could have been reduced in case VKM was used immediately after the first symptom. It did not cause any toxicity to kidney or liver or hematological parameters. The low dose and shorter duration of therapy renders safe usage without acute toxicity. Siddha literature describes to use this drug for short duration only, hence not advised for long term therapy. Hence, this is the first clinical report of Siddha medicinal mercury as a safe therapeutic agent in SARS CoV-2 infective patients with mild to moderate symptoms. This may be the synergistic effect of all the phytochemicals too. managements [20] . The Siddha term soodha giranthi denotes mercury-induced dermatitis (acrodynia), which reveals that the Siddha system had deeper knowledge and experience in using mercury as a therapeutic agent as well as the management of its toxicities using specific herbal antidotes [21] . Considering these histories and literature, one could appreciate the extensive knowledge of Siddha system in using mercury as a therapeutic agent safely in the management of severe fevers. Historically, Calomel (a mercurial salt, one of the ingredients of VKM) was used to treat yellow fever during its outbreak in Philadelphia in 1793 and also used in the treatment of syphilis. In the 18th and 19th centuries, the British doctors worked in India believed in local traditional medicine and also used Calomel for bilious fevers in a tropical environment, liver inflammation, and as a disinfectant. Later due to other better synthetic antibacterial agents, the use of mercury-based antibiotics became obsolete [22] . There is a separate hypothesis that due to the less solubility and high density, calomel gets insignificant absorption, rather it acts as a laxative and gets excreted out, so the possibilities for toxicity are less [23] . Cinnabar, one of the ingredients of VKM is chemically inert with a relatively low toxic potential when taken orally. In risk assessment, cinnabar is certainly less toxic than many other forms of mercury [24] . Earlier preclinical based research on Siddha cinnabar drug has shown the safe human dose up to 112 mg/70kg in man [25] . clinical trial on 50 rheumatoid arthritis patients using Siddha mercury drugs without any side effects [29] . Government Siddha Medical College located at Palayamkottai and Chennai, India, have been using Siddha mercury drugs for cancers, psoriasis, and AIDS patients for the past 35 years without any adverse effects [30] . Thas, et al documented his experience of using Siddha mercury-based drugs for the management of chronic severe dermatological cases for the past 30 years without side effects [31] . Another interesting point to note is the long shelf life of 75 years as per the Siddha literature, which needs to be scientifically studied and has many advantages if is so [9] . Our earlier studies on Siddha mercury-based drugs showed interesting features such as nanosize of 20-80 nm and ensured safety in in-vitro cytotoxicity assays as well as zebrafish toxicity models, that gave a novel scope for the therapeutic potential of Siddha mercurial preparations, which are different from the toxic mercurials [32] . Hence, it is understood that Siddha therapeutic mercurial preparations are possessing different properties from the laboratory mercury. VKM contains 22% mercury, 8.7% iron, and 1.3% arsenic along with 66 phytochemicals. This medicinal mercury and arsenic might have a broad spectrum activity against virus and inflammation, but these are the claims made by Siddha physicians. Future studies should be carried out to understand the mechanism of action of Siddha medicinal metals. Even though VKM contains mercury, it did not show any heavy metal toxicities in all the five cases and did not aggravate preexisting renal damage in the old age patient. The role of specific dietary practices during the mercury based drug therapy is yet to be understood. There is an urgent need for a detailed exploratory reverse pharmacological study on the therapeutic potential of this drug in COVID-19 cases. J o u r n a l P r e -p r o o f China: retrospective case series Efficacy of Traditional Chinese Medicine on COVID-19: Two Case Reports Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective Pediatric Liver Diseases and its Management by Herbals : A Siddha Medicine Diseases -Volume I (Tamil). 1st ed. Kanyakumari, India: ATSVS Siddha Medical College and Hospital Pitham, Peenisam and Suranoi (Tamil) Siro Rathina Nadana kaandam (Tamil) Scientific Analysis Of Vajra Kandi Chenduram A Siddha Formulation Towards Its Safety, Pharmacological Action And Proposed Benefits In The Management Of Covid-19 Metal based Siddha drugs for pandemic fevers based on experience (Tamil) Karpa Avizhdham publication Kannusamy Parambarai Vaidyam (Tamil) Siddha Marunthu Sei Muraigan (Tamil) Vernonia cinerea (neichitti keerai) regenerates proximal tubules in cisplatininduced renal damage in mice Correction: Physiochemical characterization and cytotoxicity evaluation of mercurybased formulation for the development of anticancer therapeuticals Clinical progression of patients with COVID-19 in Shanghai Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Vīramāmunivar Vaagada thirattu Tamil) Siddha maruthuva noi thoguthi-Volume 1 (Tamil) Calomel and the Art of kushtasāzī: Mercurial Preparations in Unani Medicine Is calomel truly a poison and what happens when it enters the human stomach? A study from the thermodynamic viewpoint in Mercury in traditional medicines: Is cinnabar toxicologically similar to common mercurials? Preparation, chemical analysis and sub-acute toxicity evaluation of linga pathangam (a mercury based Siddha herbo-metallic drug) in rats Pharmacological and Toxicological studies of Karpoora Chindhamani Mathirai (KCM) for Analgesic, Anti-inflammatory, Anti-pyretic effects in rats | International Journal of Ayurvedic Medicine Acute and Sub-Acute Toxicity Study of Siddha Herbo Mineral Formulation "Panchamuga Chendhuram" in Experimental Rats International Journal of Current Research in Medical Sciences Acute and Long-Term Toxicity Study of Poora Parpam a Herbo-Mineral Siddha Drug Efficacy of Kanaga linga karpoora mezhugu on rheumatoid arthritis Oncologists need to assess efficacy of mercury to treat cancer: Dr Arul Amuthan Siddha Medicine-background and principles and the application for skin diseases Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals Chloride -101, Bicarbonate -22 Liver function: SGOT -19 U/L, SGPT -20 U/L, Alkaline phosphatase -72 U/L, Total bilirubin -0.40 mg/dl fever (99 -100 o F), tiredness and headache Comorbid: Nil Paracetamol 21 May 2020 fever (100 o F), tiredness and headache HR 104/min, SpO2 98%, RR 20/min SpO2 97%, tiredness and headache Real Time RT PCR test for COVID-19: E-gene : Positive, RdRP-gene: Positive Fever, tiredness and headache -reduced after Vajrakandi maathirai Vajrakandi maathirai 26 -28 May -t.i.d MCV-72, MCH-23, MCHC-32, WBC-10.3, N-70, L-28, E-2, ESR -09 (½ hr.) & 20 (1 hr.), PLT -2.40, Glucose, Renal function (mg/dl): Glucose-90, Urea -15, Creatinine -0.6, Uric acid -3.2, Calcium -9.4, Phosphorus -3.2 Serum electrolytes (mEq/L): Sodium -140 Direct bilirubin -0.7 mg/dl, Indirect bilirubin Total protein -6.9 gm/dl RBc -total red blood cells millions/cmm, MCV -mean corpuscular volume/mean cell volume fml, MCH -mean corpuscular hemoglobin pg, MCHC -mean corpuscular hemoglobin concentration g/dl, WBC -Total white blood cells in 10 3 cells/cumm, N -nuetrophiles %, L -lymphocyte %, Eeosinophil %, ESR -erythrocyte sedimentation rate, ALC -absolute lymphocyte count, M -Monocyte, PLT -platelet 10 5 cells/cumm, b.d. -twice daily, h.s.-at bedtime, t.i.d.-three times daily, o.m. -morning, HR -heart rate Isopropyl-4-methyl-pent-3-en-1-ynyl)-2-methyl-cyclobutanone C14H20O 204 -methylethenyl) -methylethyl)-, (1.alpha.,4a.beta.,8a.alpha.)-(.+/-.)-Hydroxy-2,4a,6a,6b Benzoic acid, 2-methoxy ]decane, 2-methylene-5-(1-methylvinyl)-8-methyl-C15H24 Benzoic acid, 4-hydroxy-, hydrazide Cyclohexane, 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene 48 2,3,3',4'-tetramethoxy-5-(3-methoxyprop-1-enly)stilbene 4-Dimethoxybenzyl)piperazin-1-yl]-(2-methoxyphenyl)methanone C21H26N2O4